PHAT logo

Phathom Pharmaceuticals (PHAT)

Profile

Full Name

Phathom Pharmaceuticals, Inc.

Ticker Symbol

PHAT

Exchange

NASDAQ

Country

United States

IPO

October 25, 2019

Indexes

Not included

Employees

427

Key Details

Price

$4.88(+18.73%)

Market cap

$339.83M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$55.25M(+8001.47% YoY)

Annual EPS

-$5.29(-34.61% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 9, 25 Needham
Buy
Apr 2, 25 Needham
Buy
Apr 2, 25 Guggenheim
Buy
Mar 10, 25 Goldman Sachs
Neutral
Mar 7, 25 HC Wainwright & Co.
Buy
Mar 6, 25 Needham
Buy
Jan 10, 25 Needham
Buy
Dec 12, 24 HC Wainwright & Co.
Buy
Dec 11, 24 Needham
Buy
Sep 13, 24 Needham
Buy

Institutional Ownership

  • What is the ticker symbol for Phathom Pharmaceuticals?
  • Does Phathom Pharmaceuticals pay dividends?
  • What sector is Phathom Pharmaceuticals in?
  • What industry is Phathom Pharmaceuticals in?
  • What country is Phathom Pharmaceuticals based in?
  • When did Phathom Pharmaceuticals go public?
  • Is Phathom Pharmaceuticals in the S&P 500?
  • Is Phathom Pharmaceuticals in the NASDAQ 100?
  • Is Phathom Pharmaceuticals in the Dow Jones?
  • When was Phathom Pharmaceuticals's last earnings report?
  • When does Phathom Pharmaceuticals report earnings?
  • Should I buy Phathom Pharmaceuticals stock now?

What is the ticker symbol for Phathom Pharmaceuticals?

The ticker symbol for Phathom Pharmaceuticals is NASDAQ:PHAT

Does Phathom Pharmaceuticals pay dividends?

No, Phathom Pharmaceuticals does not pay dividends

What sector is Phathom Pharmaceuticals in?

Phathom Pharmaceuticals is in the Healthcare sector

What industry is Phathom Pharmaceuticals in?

Phathom Pharmaceuticals is in the Biotechnology industry

What country is Phathom Pharmaceuticals based in?

Phathom Pharmaceuticals is headquartered in United States

When did Phathom Pharmaceuticals go public?

Phathom Pharmaceuticals's initial public offering (IPO) was on October 25, 2019

Is Phathom Pharmaceuticals in the S&P 500?

No, Phathom Pharmaceuticals is not included in the S&P 500 index

Is Phathom Pharmaceuticals in the NASDAQ 100?

No, Phathom Pharmaceuticals is not included in the NASDAQ 100 index

Is Phathom Pharmaceuticals in the Dow Jones?

No, Phathom Pharmaceuticals is not included in the Dow Jones index

When was Phathom Pharmaceuticals's last earnings report?

Phathom Pharmaceuticals's most recent earnings report was on Mar 6, 2025

When does Phathom Pharmaceuticals report earnings?

The next expected earnings date for Phathom Pharmaceuticals is May 9, 2025

Should I buy Phathom Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page